Bloxiverz (neostigmine methylsulfate) Briefing Materials
For the September 14, 2016 meeting of the FDA's Pediatric Advisory Committee
Persons with disabilities having problems accessing any of the PDF files below may call 240-402-3838 for assistance.
Briefing Materials
- Bloxiverz Safety and Drug Utilization Review
- Bloxiverz Labeling, 9/2015
- Presentation: Pediatric Focused Safety Review for Bloxiverz
- Bloxiverz Clinical Review
- Bloxiverz Clinical Pharmacology Review